These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3121551)

  • 1. Selective killing of human immunodeficiency virus-infected and -producing cells by liposomes containing diphtheria toxin fragment A.
    Ikuta K; Ueda S; Uchida T; Okada Y; Kato S
    Jpn J Cancer Res; 1987 Nov; 78(11):1159-63. PubMed ID: 3121551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
    Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
    Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of diphtheria toxin A fragment to toxin-resistant murine cells delivered by pH-sensitive immunoliposomes.
    Collins D; Huang L
    Cancer Res; 1987 Feb; 47(3):735-9. PubMed ID: 3802078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HN glycoprotein of HVJ (Sendai virus) enhances the selective cytotoxicity of diphtheria toxin fragment A-containing liposomes on subacute sclerosing panencephalitis virus-infected cells.
    Uchida T; Ueda S; Nakanishi M; Miura N; Okada Y
    Exp Cell Res; 1984 Jun; 152(2):313-21. PubMed ID: 6547095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective killing of subacute sclerosing panencephalitis virus-infected cells by liposomes containing fragment A of diphtheria toxin.
    Ueda S; Uchida T; Okada Y
    Exp Cell Res; 1981 Apr; 132(2):259-63. PubMed ID: 7215444
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
    Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
    J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunization against the human immunodeficiency virus in Zaire].
    Zagury D; Salaün JJ; Bernard J; Dechazal L; Goussard B; Lurhuma Z
    Med Trop (Mars); 1988; 48(4):417-23. PubMed ID: 3221792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission and genetic shift of human immunodeficiency virus (HIV) in vivo.
    Yoshiyama H; Kobayashi N; Matsui T; Nakashima H; Kajii T; Yamato K; Kotani S; Miyoshi I; Yamamoto N
    Mol Biol Med; 1987 Dec; 4(6):385-96. PubMed ID: 3501821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible strategy to eliminate HIV-infected cells].
    Kato S; Ikuta K
    Nihon Rinsho; 1989 Jan; 47(1):213-9. PubMed ID: 2724566
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of SSPE (subacute sclerosing panencephalitis): selective killing of SSPE virus infected cells].
    Okada Y
    Rinsho Shinkeigaku; 1986 Dec; 26(12):1277-82. PubMed ID: 3829527
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective inhibitory effects of hybrid liposomes on the growth of HIV type 1-infected cells in vitro.
    Ueoka R; Komizu Y; Matsumoto Y; Zhong Y; Tanaka R; Yamamoto N
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4578-80. PubMed ID: 18672367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
    Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
    Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS.
    Zagury D; Bernard J; Cheynier R; Desportes I; Leonard R; Fouchard M; Reveil B; Ittele D; Lurhuma Z; Mbayo K
    Nature; 1988 Apr; 332(6166):728-31. PubMed ID: 3162762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
    Clayton R; Ohagen A; Nicol F; Del Vecchio AM; Jonckers TH; Goethals O; Van Loock M; Michiels L; Grigsby J; Xu Z; Zhang YP; Gutshall LL; Cunningham M; Jiang H; Bola S; Sarisky RT; Hertogs K
    Antiviral Res; 2009 Nov; 84(2):142-9. PubMed ID: 19699239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of immunotoxin against human glioma cells.
    Manome Y; Watanabe M; Ohno T
    Neurochirurgia (Stuttg); 1989 Sep; 32(5):146-9. PubMed ID: 2797358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphtheria toxin sensitivity in a monochromosomal hybrid containing human chromosome 5.
    Athwal RS; Searle BM; Jansons VK
    J Hered; 1985; 76(5):329-34. PubMed ID: 4056363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxins that are activated by HIV type-1 protease through removal of a signal for degradation by the N-end-rule pathway.
    Falnes PO; Welker R; Kräusslich HG; Olsnes S
    Biochem J; 1999 Oct; 343 Pt 1(Pt 1):199-207. PubMed ID: 10493930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression by neurotropin of production of human immuno-deficiency virus by the virus-producing MOLT-4 cell line.
    Imai H; Ikuta K; Ueda S; Suehiro S; Yamamoto N; Kato S
    Jpn J Cancer Res; 1987 Jul; 78(7):648-50. PubMed ID: 3114194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity of HIV in lymphatic organs of patients with AIDS.
    Pekovic DD; Gornitsky M; Ajdukovic D; Dupuy JM; Chausseau JP; Michaud J; Lapointe N; Gilmore N; Tsoukas C; Zwadlo G
    J Pathol; 1987 May; 152(1):31-5. PubMed ID: 3305846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.